Literature DB >> 2144458

Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat.

M L Wadenberg1, E Ericson, O Magnusson, S Ahlenius.   

Abstract

The local application of (-)sulpiride, 200 ng side-1, into the nucleus accumbens produced a suppression of conditioned avoidance behavior in male rats, 10 and 90 min after injection. The decrease in avoidance behavior was accompanied by a decrease in motor activity, as evidenced by changes in the number of intertrial crosses. When injected into the dorsolateral neostriatum, or the amygdala, (-)sulpiride produced a suppression of conditioned avoidance behavior at the 90-min time interval only. Considering diffusion from the injection site, as indicated by an increase in local dopamine turnover [(DO-PAC + HVA) DA-1], the effects obtained in the dorsolateral neostriatum, and possibly also the amygdala, 90 min after injection could be due to diffusion to the nucleus accumbens. The local application of (-)sulpiride into the posterior neostriatum, or into the prefrontal cortex, produced no statistically significant effect on conditioned avoidance behavior 10 or 90 min after injection. It is concluded that the performance of conditioned avoidance behavior in the rat is critically dependent on an intact dopaminergic neurotransmission in the nucleus accumbens or adjacent areas of the ventral striatum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144458     DOI: 10.1016/0006-3223(90)90657-n

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  29 in total

Review 1.  From reinforcement learning models to psychiatric and neurological disorders.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Nat Neurosci       Date:  2011-02       Impact factor: 24.884

Review 2.  Neurophysiology of Reward-Guided Behavior: Correlates Related to Predictions, Value, Motivation, Errors, Attention, and Action.

Authors:  Gregory B Bissonette; Matthew R Roesch
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 3.  The nucleus accumbens as part of a basal ganglia action selection circuit.

Authors:  Saleem M Nicola
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

Review 4.  The role of the striatum in aversive learning and aversive prediction errors.

Authors:  Mauricio R Delgado; Jian Li; Daniela Schiller; Elizabeth A Phelps
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-12-12       Impact factor: 6.237

Review 5.  Reassessing wanting and liking in the study of mesolimbic influence on food intake.

Authors:  Saleem M Nicola
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-17       Impact factor: 3.619

6.  Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.

Authors:  Amani Eltayb; Marie-Louise G Wadenberg; Björn Schilström; Torgny H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-12       Impact factor: 3.000

7.  Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.

Authors:  Chen Zhang; Yiru Fang; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2010-12-29       Impact factor: 3.533

8.  Dopamine D1 and D2 antagonist effects on response likelihood and duration.

Authors:  Won Yung Choi; Cecile Morvan; Peter D Balsam; Jon C Horvitz
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

9.  Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia.

Authors:  Xue Sun; Hong-yan Gou; Fei Li; Guan-yi Lu; Rui Song; Ri-fang Yang; Ning Wu; Rui-bin Su; Bin Cong; Jin Li
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

10.  Ventral striatal neurons encode the value of the chosen action in rats deciding between differently delayed or sized rewards.

Authors:  Matthew R Roesch; Teghpal Singh; P Leon Brown; Sylvina E Mullins; Geoffrey Schoenbaum
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.